1
|
Stein HJ, Feith M, Bruecher BL, Naehrig J,
Sarbia M and Siewert JR: Early esophageal cancer: Pattern of
lymphatic spread and prognostic factors for long-term survival
after surgical resection. Ann Surg. 242:566–575. 2005.PubMed/NCBI
|
2
|
Bollschweiler E, Plum P, Mönig SP and
Hölscher AH: Current and future treatment options for esophageal
cancer in the elderly. Expert Opin Pharmacother. 18:1001–1010.
2017. View Article : Google Scholar : PubMed/NCBI
|
3
|
Suntharalingam M, Winter K, Ilson D,
Dicker AP, Kachnic L, Konski A, Chakravarthy AB, Anker CJ, Thakrar
H, Horiba N, et al: Effect of the addition of cetuximab to
paclitaxel, cisplatin, and radiation therapy for patients with
esophageal cancer: The NRG oncology RTOG 0436 Phase 3 randomized
clinical trial. JAMA Oncol. 3:1520–1528. 2017. View Article : Google Scholar : PubMed/NCBI
|
4
|
Shao L, Zhang B, Wang L, Wu L, Kan Q and
Fan K: MMP-9-cleaved osteopontin isoform mediates tumor immune
escape by inducing expansion of myeloid-derived suppressor cells.
Biochem Biophys Res Commun. 493:1478–1484. 2017. View Article : Google Scholar : PubMed/NCBI
|
5
|
Matsuda S, Tsubosa Y, Sato H, Takebayashi
K, Kawamorita K, Mori K, Niihara M, Tsushima T, Yokota T, Onozawa
Y, et al: Comparison of neoadjuvant chemotherapy versus upfront
surgery with or without chemotherapy for patients with clinical
stage III esophageal squamous cell carcinoma. Dis Esophagus.
30:1–8. 2017.
|
6
|
Cheng YF, Chen HS, Wu SC, Chen HC, Hung
WH, Lin CH and Wang BY: Esophageal squamous cell carcinoma and
prognosis in Taiwan. Cancer Med. 7:4193–4201. 2018. View Article : Google Scholar : PubMed/NCBI
|
7
|
Sun Y, Zhang T, Wu W, Zhao D, Zhang N, Cui
Y, Liu Y, Gu J, Lu P, Xue F, et al: Risk factors associated with
precancerous lesions of esophageal squamous cell carcinoma: A
screening study in a high risk chinese population. J Cancer.
10:3284–3290. 2019. View Article : Google Scholar : PubMed/NCBI
|
8
|
Wang LD, Zhou FY, Li XM, Sun LD, Song X,
Jin Y, Li JM, Kong GQ, Qi H, Cui J, et al: Genome-wide association
study of esophageal squamous cell carcinoma in Chinese subjects
identifies susceptibility loci at PLCE1 and C20orf54. Nat Genet.
42:759–763. 2010. View
Article : Google Scholar : PubMed/NCBI
|
9
|
Cheng Y, Xing SG, Jia WD, Huang M and Bian
NN: Low PLCE1 levels are correlated with poor prognosis in
hepatocellular carcinoma. Onco Targets Ther. 10:47–54. 2017.
View Article : Google Scholar : PubMed/NCBI
|
10
|
Wang Q, Chen P, Chen D, Liu F and Pan W:
Association between phospholipase C epsilon gene (PLCE1)
polymorphism and colorectal cancer risk in a Chinese population. J
Int Med Res. 42:270–281. 2014. View Article : Google Scholar : PubMed/NCBI
|
11
|
Liang P, Zhang W, Wang W, Dai P, Wang Q,
Yan W, Wang W, Lei X, Cui D and Yan Z: PLCE1 polymorphisms
and risk of esophageal and gastric cancer in a northwestern chinese
population. Biomed Res Int. 2019:97651912019. View Article : Google Scholar : PubMed/NCBI
|
12
|
Ou L, Guo Y, Luo C, Wu X, Zhao Y and Cai
X: RNA interference suppressing PLCE1 gene expression decreases
invasive power of human bladder cancer T24 cell line. Cancer Genet
Cytogenet. 200:110–119. 2010. View Article : Google Scholar : PubMed/NCBI
|
13
|
Chen Y, Wang D, Peng H, Chen X, Han X, Yu
J, Wang W, Liang L, Liu Z, Zheng Y, et al: Epigenetically
upregulated oncoprotein PLCE1 drives esophageal carcinoma
angiogenesis and proliferation via activating the
PI-PLCepsilon-NF-κB signaling pathway and VEGF-C/ Bcl-2 expression.
Mol Cancer. 18:12019. View Article : Google Scholar : PubMed/NCBI
|
14
|
Cui XB, Li S, Li TT, Peng H, Jin TT, Zhang
SM, Liu CX, Yang L, Shen YY, Li SG, et al: Targeting oncogenic
PLCE1 by miR-145 impairs tumor proliferation and metastasis of
esophageal squamous cell carcinoma. Oncotarget. 7:1777–1795. 2016.
View Article : Google Scholar : PubMed/NCBI
|
15
|
Cui XB, Peng H, Li RR, Mu JQ, Yang L, Li
N, Liu CX, Hu JM, Li SG, Wei Y, et al: MicroRNA-34a functions as a
tumor suppressor by directly targeting oncogenic PLCE1 in Kazakh
esophageal squamous cell carcinoma. Oncotarget. 8:92454–92469.
2017. View Article : Google Scholar : PubMed/NCBI
|
16
|
Chen Y, Xin H, Peng H, Shi Q, Li M, Yu J,
Tian Y, Han X, Chen X, Zheng Y, et al: Hypomethylation-linked
activation of PLCE1 impedes autophagy and promotes tumorigenesis
through MDM2-mediated ubiquitination and destabilization of p53.
Cancer Res. 80:2175–2189. 2020.PubMed/NCBI
|
17
|
Zhai S, Liu C, Zhang L, Zhu J, Guo J,
Zhang J, Chen Z, Zhou W, Chang T, Xu S, et al: PLCE1 promotes
esophageal cancer cell progression by maintaining the
transcriptional activity of snail. Neoplasia. 19:154–164. 2017.
View Article : Google Scholar : PubMed/NCBI
|
18
|
Qi X, Zhang DH, Wu N, Xiao JH, Wang X and
Ma W: ceRNA in cancer: Possible functions and clinical
implications. J Med Genet. 52:710–718. 2015. View Article : Google Scholar : PubMed/NCBI
|
19
|
Hu X, Li Y, Kong D, Hu L, Liu D and Wu J:
Long noncoding RNA CASC9 promotes LIN7A expression via miR-758-3p
to facilitate the malignancy of ovarian cancer. J Cell Physiol.
234:10800–10808. 2019. View Article : Google Scholar : PubMed/NCBI
|
20
|
Yang J, Qiu Q, Qian X, Yi J, Jiao Y, Yu M,
Li X, Li J, Mi C, Zhang J, et al: Long noncoding RNA LCAT1
functions as a ceRNA to regulate RAC1 function by sponging
miR-4715-5p in lung cancer. Mol Cancer. 18:1712019. View Article : Google Scholar : PubMed/NCBI
|
21
|
Chen J, Yu Y, Li H, Hu Q, Chen X, He Y,
Xue C, Ren F, Ren Z, Li J, et al: Long non-coding RNA PVT1 promotes
tumor progression by regulating the miR-143/HK2 axis in gallbladder
cancer. Mol Cancer. 18:332019. View Article : Google Scholar : PubMed/NCBI
|
22
|
Robinson MD, McCarthy DJ and Smyth GK:
edgeR: A Bioconductor package for differential expression analysis
of digital gene expression data. Bioinformatics. 26:139–140. 2010.
View Article : Google Scholar : PubMed/NCBI
|
23
|
Tomczak K, Czerwińska P and Wiznerowicz M:
The cancer genome atlas (TCGA): An immeasurable source of
knowledge. Contemp Oncol (Pozn). 19(1A):A68–A77. 2015.
|
24
|
Arora A and Simpson DA: Simpson,
Individual mRNA expression profiles reveal the effects of specific
microRNAs. Genome Biol. 9:R822008. View Article : Google Scholar : PubMed/NCBI
|
25
|
Huang HY, Lin YC, Li J, Huang KY, Shrestha
S, Hong HC, Tang Y, Chen YG, Jin CN, Yu Y, et al: miRTarBase 2020:
Updates to the experimentally validated microRNA-target interaction
database. Nucleic Acids Res. 48:D148–D154. 2019.
|
26
|
Chen Y and Wang X: miRDB: An online
database for prediction of functional microRNA targets. Nucleic
Acids Res. 48:D127–D131. 2019. View Article : Google Scholar
|
27
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI
|
28
|
Zhou Y, Zhou B, Pache L, Chang M,
Khodabakhshi AH, Tanaseichuk O, Benner C and Chanda SK: Metascape
provides a biologist-oriented resource for the analysis of
systems-level datasets. Nat Commun. 10:15232019. View Article : Google Scholar : PubMed/NCBI
|
29
|
Szklarczyk D, Gable AL, Lyon D, Junge A,
Wyder S, Huerta-Cepas J, Simonovic M, Doncheva NT, Morris JH, Bork
P, et al: STRING v11: Protein-protein association networks with
increased coverage, supporting functional discovery in genome-wide
experimental datasets. Nucleic Acids Res. 47:D607–D613. 2019.
View Article : Google Scholar : PubMed/NCBI
|
30
|
Zhang SW, Zheng RS, Zuo TT, Zeng HM, Chen
WQ and He J: Mortality and survival analysis of esophageal cancer
in China. Zhonghua Zhong Liu Za Zhi. 38:709–715. 2016.(In Chinese).
PubMed/NCBI
|
31
|
Domper Arnal MJ, Ferrández Arenas Á and
Lanas Arbeloa Á: Esophageal cancer: Risk factors, screening and
endoscopic treatment in Western and Eastern countries. World J
Gastroenterol. 21:7933–7943. 2015. View Article : Google Scholar : PubMed/NCBI
|
32
|
Liang Y, Chen X, Wu Y, Li J, Zhang S, Wang
K, Guan X, Yang K and Bai Y: LncRNA CASC9 promotes esophageal
squamous cell carcinoma metastasis through upregulating LAMC2
expression by interacting with the CREB-binding protein. Cell Death
Differ. 25:1980–1995. 2018. View Article : Google Scholar : PubMed/NCBI
|
33
|
Li Z, Qin X, Bian W, Li Y, Shan B, Yao Z
and Li S: Exosomal lncRNA ZFAS1 regulates esophageal squamous cell
carcinoma cell proliferation, invasion, migration and apoptosis via
microRNA-124/STAT3 axis. J Exp Clin Cancer Res. 38:4772019.
View Article : Google Scholar : PubMed/NCBI
|
34
|
Jiang L, Wang R, Fang L, Ge X, Chen L,
Zhou M, Zhou Y, Xiong W, Hu Y, Tang X, et al: HCP5 is a
SMAD3-responsive long non-coding RNA that promotes lung
adenocarcinoma metastasis via miR-203/SNAI axis. Theranostics.
9:2460–2474. 2019. View Article : Google Scholar : PubMed/NCBI
|
35
|
Liang Q, Li X, Guan G, Xu X, Chen C, Cheng
P, Cheng W and Wu A: Long non-coding RNA, HOTAIRM1, promotes glioma
malignancy by forming a ceRNA network. Aging (Albany NY).
11:6805–6838. 2019. View Article : Google Scholar : PubMed/NCBI
|
36
|
Tang Z, Kang B, Li C, Chen T and Zhang Z:
GEPIA2: An enhanced web server for large-scale expression profiling
and interactive analysis. Nucleic Acids Res. 47:W556–W560. 2019.
View Article : Google Scholar : PubMed/NCBI
|
37
|
Gebert LFR and MacRae IJ: Regulation of
microRNA function in animals. Nat Rev Mol Cell Biol. 20:21–37.
2019. View Article : Google Scholar : PubMed/NCBI
|
38
|
Kong YW, Ferland-McCollough D, Jackson TJ
and Bushell M: microRNAs in cancer management. Lancet Oncol.
13:e249–e258. 2012. View Article : Google Scholar : PubMed/NCBI
|
39
|
Li Z, Peng Z, Gu S, Zheng J, Feng D, Qin Q
and He J: Global analysis of miRNA-mRNA interaction network in
breast cancer with brain metastasis. Anticancer Res. 37:4455–4468.
2017.PubMed/NCBI
|
40
|
Dong HX, Wang R, Jin XY, Zeng J and Pan J:
LncRNA DGCR5 promotes lung adenocarcinoma (LUAD) progression via
inhibiting hsa-mir-22-3p. J Cell Physiol. 233:4126–4136. 2018.
View Article : Google Scholar : PubMed/NCBI
|
41
|
Chen Z, Zhang M, Qiao Y, Yang J and Yin Q:
MicroRNA-1297 contributes to the progression of human cervical
carcinoma through PTEN. Artif Cells Nanomed Biotechnol. 46 (Suppl
2):1120–1126. 2018. View Article : Google Scholar : PubMed/NCBI
|
42
|
Cui X, Xin H, Peng H and Chen Y:
Comprehensive bioinformatics analysis of the mRNA profile of PLCE1
knockdown in esophageal squamous cell carcinoma. Mol Med Rep.
16:5871–5880. 2017. View Article : Google Scholar : PubMed/NCBI
|
43
|
Vishnubalaji R, Yue S, Alfayez M, Kassem
M, Liu FF, Aldahmash A and Alajez NM: Bone morphogenetic protein 2
(BMP2) induces growth suppression and enhances chemosensitivity of
human colon cancer cells. Cancer Cell Int. 16:772016. View Article : Google Scholar : PubMed/NCBI
|
44
|
Zou J, Li S, Chen Z, Lu Z, Gao J, Zou J,
Lin X, Li Y, Zhang C and Shen L: A novel oral camptothecin analog,
gimatecan, exhibits superior antitumor efficacy than irinotecan
toward esophageal squamous cell carcinoma in vitro and in vivo.
Cell Death Dis. 9:6612018. View Article : Google Scholar : PubMed/NCBI
|
45
|
Shimizu H, Shiozaki A, Ichikawa D,
Fujiwara H, Konishi H, Ishii H, Komatsu S, Kubota T, Okamoto K,
Kishimoto M and Otsuji E: The expression and role of Aquaporin 5 in
esophageal squamous cell carcinoma. J Gastroenterol. 49:655–666.
2014. View Article : Google Scholar : PubMed/NCBI
|
46
|
Qin YR, Tang H, Xie F, Liu H, Zhu Y, Ai J,
Chen L, Li Y, Kwong DL, Fu L and Guan XY: Characterization of
tumor-suppressive function of SOX6 in human esophageal squamous
cell carcinoma. Clin Cancer Res. 17:46–55. 2011. View Article : Google Scholar : PubMed/NCBI
|
47
|
Li L, Zhang C, Li X, Lu S and Zhou Y: The
candidate tumor suppressor gene ECRG4 inhibits cancer cells
migration and invasion in esophageal carcinoma. J Exp Clin Cancer
Res. 29:1332010. View Article : Google Scholar : PubMed/NCBI
|
48
|
Yuan JH, Yang F, Wang F, Ma JZ, Guo YJ,
Tao QF, Liu F, Pan W, Wang TT, Zhou CC, et al: A long noncoding RNA
activated by TGF-β promotes the invasion-metastasis cascade in
hepatocellular carcinoma. Cancer Cell. 25:666–681. 2014. View Article : Google Scholar : PubMed/NCBI
|